Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Rachel Goodwin

Interventional Cardiology Knoxville, TN Doctor of Osteopathy

NPI 1295266294 CMS profile 4508143

1819 Clinch Ave Ste 108, Knoxville, TN 37916

Open in the dashboard

General payments

$73,873

222 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rachel Goodwin of Knoxville, TN is reported in the CMS Open Payments database as having received $73,873 across 222 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,450 44
2024 General $67,258 79
2023 General $2,028 52
2022 General $1,288 26
2021 General $220 4
2020 General $628 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rachel Goodwin
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Rachel Goodwin were reported at $2,450. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Rachel Goodwin Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $628 $473 $161–$1,480 $114
2021 $220 $677 $233–$1,827 $132
2022 $1,288 $978 $333–$2,724 $149
2023 $2,028 $1,136 $382–$2,986 $160
2024 $67,258 $1,181 $395–$3,326 $164
2025 $2,450 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medtronic, Inc. $32,196 40 payments
  2. Abbott Laboratories $17,977 34 payments
  3. Boston Scientific Corporation $16,012 33 payments
  4. Edwards Lifesciences Corporation $4,358 35 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $787 29 payments
  6. Abiomed $421 10 payments
  7. Biosense Webster, Inc. $320 4 payments
  8. Shockwave Medical, Inc $308 4 payments
  9. Philips Electronics North America Corporation $294 2 payments
  10. AstraZeneca Pharmaceuticals LP $251 4 payments
  11. Other $948 27 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Grant $60,000 3 payments
  2. Food and Beverage $9,051 194 payments
  3. Travel and Lodging $4,118 20 payments
  4. Education $703 5 payments
Products named General payments · program years 2020–2025
  1. COREVALVE EVOLUT R $31,242 26 payments
  2. PASCAL $3,241 30 payments
  3. MITRACLIP $1,259 13 payments
  4. LifeVest $787 29 payments
  5. Impella $421 10 payments
  6. RESOLUTE ONYX $350 4 payments
  7. CARDIOMEMS $324 3 payments
  8. Carto 3 $320 4 payments
  9. ENSITE PRECISION $286 6 payments
  10. EVOQUE $285 2 payments
  11. Other $4,489 91 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

222 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record